Cybin (CYBN) Price & Analysis

Compare

527 Followers

CYBN Stock Chart & Stats

Day’s Range― - ―

52-Week RangeC$0.14 - C$0.14

Previous CloseN/A

Volume13.54K

Average Volume (3M)0.00

Market Cap

$1.97M

Enterprise ValueN/A

Total Cash (Recent Filing)$136.29M

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

BetaN/A

Next Earnings

Nov 17, 2025

EPS Estimate

-1.33

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding23,590,025

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$109.70

Price Target Upside78255.99% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering5

Bulls Say, Bears Say

Bulls Say

Drug DevelopmentCYB003’s 71% remission rate at 12 months following two 16 mg doses, coupled with its FDA Breakthrough Therapy Designation, underscore meaningful registration potential.

Financial PositionThe recent announcement of a US$500 million convertible debenture facility—with US$50 million now funded—provides additional capital flexibility and extends runway beyond 2026.

Market OpportunityCYBN's CYB003 (deuterated psilocin analog) is in a Phase 3 program for adjunctive treatment of major depressive disorder, which presents a significant market opportunity.

Bears Say

Price Target AdjustmentThe price target was adjusted from $73 to $70.

Valuation ConcernsCYBN still does not ascribe any value for CYB004 for generalized anxiety disorder in the valuation, viewing the product as not reflected in the stock in any appreciable way.

Cybin News

Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

8d ago

CYBN

DRUG

Cybin completes enrollment in CYB004 study

Cybin (CYBN) announced completion of enrollment in its Phase 2 study evaluating CYB004, a proprietary deuterated dimethyltryptamine program,...

11d ago

CYBN

Psychedelic: Bright Minds reports preclinical BMB-201 results

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

15d ago

CMPS

CYBN

Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint

Markets reopened after the Labor Day break on softer footing, with futures tied to the major indexes pointing...

17d ago

NIO

PEP

Cybin CEO Doug Drysdale steps down

Cybin (CYBN) announced that, effective September 2, Doug Drysdale will step down as the company’s CEO. The company’s...

17d ago

CYBN

Psychedelic: Exclusive talk with biopharma company Reunion Neuroscience

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Greg Mayes, President and Chief Executive...

22d ago

ATAI

CMND

Cybin receives Australian approval for EMBRACE study

Cybin (CYBN) announced that it has received approval in Australia to conduct the EMBRACE study. Embrace is the...

24d ago

CYBN

Cybin Inc. Strengthens U.S. Market Position with New SEC Filing

Cybin ( ($TSE:CYBN) ) has issued an update. On September 17, 2025, Cybin Inc. filed a Form 6-K...

21h ago

CYBN

Cybin Inc. Announces CEO Transition as of September 2, 2025

Cybin ( ($TSE:CYBN) ) has issued an update. On September 2, 2025, Cybin Inc. announced a significant leadership...

2d ago

CYBN

Cybin’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Cybin, with a...

7d ago

CYBN

Cybin to Engage in TD Cowen’s Neuropsychiatry Summit

Cybin ( ($TSE:CYBN) ) has provided an update. Cybin announced its participation in TD Cowen’s 5th Annual Novel...

8d ago

CYBN

Cybin Completes Enrollment in Phase 2 Study for GAD Treatment

Cybin ( ($TSE:CYBN) ) has provided an update. Cybin has completed enrollment in its Phase 2 study evaluating...

11d ago

CYBN

Cybin to Engage at H.C. Wainwright Investment Conference

The latest announcement is out from Cybin ( ($TSE:CYBN) ). Cybin announced that its Chief Business Officer, George...

15d ago

CYBN

Cybin to Engage at Cantor Global Healthcare Conference 2025

Cybin ( ($TSE:CYBN) ) has shared an update. Cybin announced that its Chief Medical Officer, Amir Inamdar, will...

16d ago

CYBN

CYBN FAQ

What was Cybin’s price range in the past 12 months?

Cybin lowest stock price was C$0.14 and its highest was C$0.14 in the past 12 months.

What is Cybin’s market cap?

Cybin’s market cap is $1.97M.

When is Cybin’s upcoming earnings report date?

Cybin’s upcoming earnings report date is Nov 17, 2025 which is in 59 days.

How were Cybin’s earnings last quarter?

Currently, no data Available

Is Cybin overvalued?

According to Wall Street analysts Cybin’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Cybin pay dividends?

Cybin does not currently pay dividends.

What is Cybin’s EPS estimate?

Cybin’s EPS estimate is -1.33.

How many shares outstanding does Cybin have?

Cybin has 23,590,025 shares outstanding.

What happened to Cybin’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Cybin?

Currently, no hedge funds are holding shares in TSE:CYBN

Company Description

Cybin

Cybin (CYBN) is a biotechnology company focused on advancing psychedelic therapeutics for mental health disorders. Operating primarily in the pharmaceutical sector, Cybin is dedicated to the research and development of psychedelic compounds, aiming to improve patient outcomes through novel drug formulations and delivery systems. The company's core services include clinical trials, drug development, and partnerships with research institutions to explore the therapeutic potential of psychedelics.

Cybin (CYBN) Earnings & Revenues

Historic Earnings Reports

CYBN Stock 12 Month Forecast

Average Price Target

C$109.70

▲(78255.99% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"51":"C$51","103":"C$103","155":"C$155","207":"C$207","-1":"-C$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":206.7180615,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$206.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":109.698384636,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$109.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.45301025,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$34.45</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,51,103,155,207],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.135,16.026004730769234,31.917009461538466,47.808014192307695,63.69901892307693,79.59002365384616,95.4810283846154,111.37203311538464,127.26303784615386,143.15404257692308,159.0450473076923,174.93605203846155,190.82705676923078,{"y":206.7180615,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.135,8.562952664307693,16.990905328615387,25.41885799292308,33.84681065723077,42.274763321538465,50.702715985846154,59.130668650153844,67.55862131446155,75.98657397876924,84.41452664307694,92.84247930738462,101.27043197169232,{"y":109.698384636,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.135,2.7748469423076925,5.414693884615384,8.054540826923077,10.694387769230769,13.33423471153846,15.974081653846154,18.613928596153848,21.25377553846154,23.89362248076923,26.533469423076923,29.173316365384615,31.81316330769231,{"y":34.45301025,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.135,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >